Discontinued — last reported Q4 '25
Business Segments · Goodwill, Impaired, Accumulated Impairment Loss
CarelonRx Segment — Goodwill, Impaired, Accumulated Impairment Loss
This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementSegment
CategoryRisk
SignalLower is better
VolatilityStable
First reportedQ4 2022
Last reportedQ4 2025
Rolls up toGoodwill accumulated impairment losses
How to read this metric
An increase signals that previous acquisitions have failed to meet performance expectations, potentially indicating structural issues in the segment.
Detailed definition
The cumulative amount of impairment charges recognized against the goodwill associated with the CarelonRx segment. This...
Peer comparison
Comparable to 'Accumulated Impairment Losses' on goodwill reported by any public company under GAAP or IFRS.
Metric ID:
elv_segment_carelonrx_goodwill_impaired_accumulated_impairment_lossHistorical Data
4 periods
| Q4 '22 | Q4 '23 | Q4 '24 | Q4 '25 | |
|---|---|---|---|---|
| Value | $0.00 | $0.00 | $0.00 | $0.00 |
Range$0.00 – $0.00
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Elevance Health's carelonrx segment — goodwill, impaired, accumulated impairment loss?
- Elevance Health (ELV) reported carelonrx segment — goodwill, impaired, accumulated impairment loss of $0.00 in Q4 2025.
- What does carelonrx segment — goodwill, impaired, accumulated impairment loss mean?
- The total historical loss in value recognized for goodwill within the pharmacy services segment.